Calendar iBio, Inc.

Equities

IBIO

US4510337086

Market Closed - Nyse 16:10:00 2024-04-26 EDT 5-day change 1st Jan Change
1.76 USD +2.33% Intraday chart for iBio, Inc. +2.33% +28.47%

Chart calendar iBio, Inc.

4471a2757de515f32aa238c423.mSLssnmxLrj0fbI4s6iAuEUyPeNwvIinJ2jlDB3-JX4.1hq17RPzTOK1TeRN7M3K2ylcTo0xyNryahmqRHiREjnqToTTMNxZ6Z4wxQ~704ae852e48a74faa3e86c0ee03bdb56

Upcoming events on iBio, Inc.

2024-05-09 Q3 2024 Earnings Release (Projected)
2024-09-23 Q4 2024 Earnings Release (Projected)

Past events on iBio, Inc.

2024-03-27 08:30 Business Update Call
2024-01-16 20:15 PepTalk Conference
2023-11-28 Reverse Split: 1 of 20
2023-11-27 16:00 Annual General Meeting
2023-10-12 06:20 Biologics Festival - Enhancing Bispecific T Cell Engager Discovery
2023-10-10 08:20 Biologics Festival - Pitfalls to Avoid When Building an AI-Driven Platform Company
2023-09-27 16:19 Q4 2023 Earnings Release
2023-05-16 12:00 JMP Securities Life Sciences Conference - Fireside Chat
2022-12-07 13:20 JMP Securities Hematology and Oncology Summit
2022-12-03 Antibody Engineering & Therapeutics Conference - Epitope-Targeted
2022-12-03 Antibody Engineering & Therapeutics Conference - Fully Human & Developable Antibody
2022-10-09 Reverse Split: 1 of 25
2022-09-27 16:30 FY 2022 Earnings Call
2022-09-27 16:10 FY 2022 Earnings Release
2022-06-30 09:30 Extraordinary Shareholders Meeting
2022-05-23 H.C. Wainwright Global Life Sciences Investment Conference
2022-05-12 16:30 Q3 2022 Earnings Call
2022-05-12 16:05 Q3 2022 Earnings Release
2022-05-01 Protein & Antibody Engineering Summit Boston Conference & Expo
2022-03-17 14:40 Oppenheimer Healthcare Conference

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
2,02


1,64
0,60
173%
2,37
2,60
-8.81%
2,38
2,50
-4.68%
0,39
0,50
-21.8%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-14,0
-15,9
11.93%
-31,1
-29,5
-5.46%
-49,7
-43,2
-15.02%
0,00
0,00
-
Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Net income
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EPS
USD
Released
Forecast
Spread
-470


0,00
0,00
-
0,00
0,00
-
-116
-115
-0.52%
0,00
0,00
-
Announcement Date26/08/1913/10/2027/09/2111/10/2227/09/23

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2
Net sales
Million USD
Released
Forecast
Spread
0,17
0,25
-32.8%
1,94
0,20
871.5%
0,06
0,20
-69.5%
0,00
0,60
-
0,13
0,60
-78.33%
0,21
0,20
2.5%
0,00
0,20
-
0,00


EBIT
Million USD
Released
Forecast
Spread
-11,6
-9,56
-21.72%
-12,2
-11,4
-6.86%
-16,9
-12,2
-38.49%
-7,64
-17,9
57.34%
-10,6
-6,80
-55.49%









Net income
Million USD
Released
Forecast
Spread
-11,9
-9,53
-25.34%





















EPS
USD
Released
Forecast
Spread
-25,0
-20,0
-25%
-30,0
-30,0
0%
-113
-40,0
-181.5%
-41,0
-35,0
-17.14%









-4,42


Announcement Date14/02/2212/05/2211/10/2214/11/2214/02/2315/05/2327/09/2315/02/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise